Literature DB >> 12076303

IgE-mediated asthma and rhinitis I: a role of allergen exposure?

Gunnar D Nielsen1, Jitka S Hansen, Rikke M Lund, Mette Bergqvist, Søren T Larsen, Susanne K Clausen, Peter Thygesen, Otto M Poulsen.   

Abstract

Exposures to airborne protein antigens, aeroallergens, may cause sensitization with production of Th2-dependent antibodies, including IgE. The IgE antibodies and associated cellular responses are responsible for the allergic airway diseases, allergic rhinitis and allergic asthma, which are increasing in societies with Western life style. Aeroallergens may have different potential to sensitize exposed subjects. Thus, there are only a limited number of important groups of aeroallergens, which are those from house dust mites, cockroaches, pets, pollens, and moulds. Allergy follows to a certain extent the pharmacological/toxicological paradigm of dose-response relationship. Unlike effects of pharmacologically and toxicologically active substances, allergens elicit their adverse effects in a two-stage process. In the first stage the immunologically naïve individual is sensitized to the allergen. In the second stage renewed exposure to the allergen elicits the disease response. Also, high concentrations of aeroallergens may induce immunological tolerance. The scientific literature suggests that many environmental factors contribute to the increase in sensitization and development of airway allergies. Nevertheless, the dose-response relationships apply (within certain limits) both to the sensitization itself and to the exacerbation of the diseases. This suggest that exposure reduction may be one of the methods for reduction of risk, in relation to control of the allergic airway diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076303     DOI: 10.1034/j.1600-0773.2002.900502.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  10 in total

Review 1.  Potential roles in rhinitis for protease and other enzymatic activities of allergens.

Authors:  Nita Sehgal; Adnan Custovic; Ashley Woodcock
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

2.  Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.

Authors:  Mairi C Noverr; Nicole R Falkowski; Rod A McDonald; Andrew N McKenzie; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Are we getting enough allergens?

Authors:  Allan Linneberg
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

Review 4.  Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.

Authors:  N Landolina; F Levi-Schaffer
Journal:  Br J Pharmacol       Date:  2016-02-01       Impact factor: 8.739

5.  Correlation of light transmittance with asthma attack: fine water particles as a possible inducing factor of asthma.

Authors:  Kazuo Kanaya; Koji Okamoto; Shinichiro Shimbo; Masayuki Ikeda
Journal:  Environ Health Prev Med       Date:  2010-07-15       Impact factor: 3.674

Review 6.  Air pollution: impact and prevention.

Authors:  Martha Patricia Sierra-Vargas; Luis M Teran
Journal:  Respirology       Date:  2012-10       Impact factor: 6.424

7.  Does climate mould the influence of mold on asthma?

Authors:  Ashutosh Nath Aggarwal; Arunaloke Chakrabarti
Journal:  Lung India       Date:  2013-10

Review 8.  Aeroallergens, allergic disease, and climate change: impacts and adaptation.

Authors:  Colleen E Reid; Janet L Gamble
Journal:  Ecohealth       Date:  2009-09       Impact factor: 3.184

9.  Experiences from occupational exposure limits set on aerosols containing allergenic proteins.

Authors:  Gunnar D Nielsen; Søren T Larsen; Jitka S Hansen; Lars K Poulsen
Journal:  Ann Occup Hyg       Date:  2012-07-28

10.  Impacts of oak pollen on allergic asthma in the United States and potential influence of future climate change.

Authors:  Susan C Anenberg; Kate R Weinberger; Henry Roman; James E Neumann; Allison Crimmins; Neal Fann; Jeremy Martinich; Patrick L Kinney
Journal:  Geohealth       Date:  2017-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.